| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042128 Electroprocessed fibrin-based matrices and tissues |
| 04/11/2002 | US20020042103 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | US20020041907 Therapy for both intrinsic and extrinsic aging |
| 04/11/2002 | US20020041890 Skin care cosmetic compositions containing phosphates and/or sulfates of branched alcohols and/or ethoxylates thereof |
| 04/11/2002 | US20020041883 Topical applying |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041873 Administering neutrotrophic factor inhibitor |
| 04/11/2002 | DE10048683A1 Zubereitung von Emulsionstyp W/O mit erhöhtem Wassergehalt auf der Basis niedrigviskoser,gut spreitender Lipidkomponenten,ferner enthaltend ein oder mehrere Alkylmethiconcopolyole und/oder Alkyl-Dimethicopolyole Preparation of Emulsion W / O type with increased water content based on low, well spreitender lipid components, further comprising one or more alkylmethicone copolyols and / or alkyl Dimethicopolyole |
| 04/11/2002 | DE10048260A1 Cosmetic or dermatological composition for combating undesirable skin pigmentation, contains aminoguanidine or its derivatives |
| 04/11/2002 | DE10047250A1 Emulgatorfreie feindisperse Systeme vom Typ Wasser-in-Öl mit einem Gehalt an Ethylcellulose Emulsifier-free finely dispersed systems of the water-in-oil containing ethyl cellulose |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425266A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2425092A1 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | CA2424783A1 Concordantly uv-photoprotecting and artificial tanning compositions |
| 04/11/2002 | CA2424749A1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424303A1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | CA2424296A1 Human anti-cd40 antibodies |
| 04/11/2002 | CA2424282A1 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423888A1 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423656A1 Methods and compositions for enhancing angiogenesis |
| 04/10/2002 | EP1195605A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195604A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195378A1 Pyridotriazines and pyridopyridazines |
| 04/10/2002 | EP1195156A1 Use of an ericaceae extract in skin-ageing treatment |
| 04/10/2002 | EP1194590A2 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194443A1 Cysteinyl protease inhibitors |
| 04/10/2002 | EP1194422A1 Biaryl compounds |
| 04/10/2002 | EP1194411A1 Benzoylpyridazines |
| 04/10/2002 | EP1194405A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors |
| 04/10/2002 | EP1194172A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194152A1 Src kinase inhibitor compounds |
| 04/10/2002 | EP1194150A1 Use of nitroxides in wound healing and in the prevention of photodamage |
| 04/10/2002 | EP1194136A1 Non-solid composition for local application |
| 04/10/2002 | EP1194115A1 Topically applied idebenone-containing agent with protective and regenerative effect |
| 04/10/2002 | EP1194109A1 Topical formulations comprising skin penetration agents and the use thereof |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0771191B1 Immunological activity of rhamnolipids |
| 04/10/2002 | EP0768866B1 Desquamation compositions |
| 04/10/2002 | EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344314A Sebocytes, sebocyte cell lines and applications thereof |
| 04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344266A Novel compounds |
| 04/10/2002 | CN1344250A 间苯二酚衍生物 Resorcinol derivatives |
| 04/10/2002 | CN1344249A 酰胺衍生物 Amide derivatives |
| 04/10/2002 | CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344161A Use of pyridazino [4,5-i(b)]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 04/10/2002 | CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 04/10/2002 | CN1344159A Combinations for treatment of diseases involving angiogenesis |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1344154A Absorbent article compsn. and method of use for sequestering skin irritants |
| 04/10/2002 | CN1344153A Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 04/10/2002 | CN1344152A Resorcinol compsn. |
| 04/10/2002 | CN1343517A Medicine for treating dermatopathy and its preparing process |
| 04/10/2002 | CN1343516A Medicine for nourishing liver, kidney and hair and beautifying face and its preparing process |
| 04/10/2002 | CN1343510A Psoriasis-recovering liquid |
| 04/10/2002 | CN1343506A Chinese patent medicine for treating allergic dermatopathy |
| 04/10/2002 | CN1343500A External-applied broad-spectrum detoxicating medicine for relieving inflammation |
| 04/10/2002 | CN1343499A Prescription of ephedra herb ointment |
| 04/10/2002 | CN1082372C Liquid medicine for treating bromidrosis, and its prepn. method |
| 04/10/2002 | CN1082369C Formulations contg. carotenoids and procarotenoids combined with polyphenols |
| 04/10/2002 | CN1082364C Skin nutritious agent |
| 04/09/2002 | US6369289 Method and manufacture of a wound dressing for covering an open wound |
| 04/09/2002 | US6369100 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| 04/09/2002 | US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation |
| 04/09/2002 | US6369089 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369032 Method for treating allergies |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368608 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/09/2002 | US6368606 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 04/09/2002 | US6368594 Pure polypeptide |
| 04/09/2002 | CA2298572C Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/09/2002 | CA2171675C Aromatic heterocyclic compounds; pharmaceutical and cosmetic compositions containing the same and their uses |
| 04/09/2002 | CA2084790C Endonucleases |
| 04/05/2002 | CA2357862A1 Use of at least one extract from at least one plant from the ericaceae family in compositions for treating skin showing signs of old age |
| 04/04/2002 | WO2002027318A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
| 04/04/2002 | WO2002026962A1 Method of examining allergic disease |
| 04/04/2002 | WO2002026940A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells |
| 04/04/2002 | WO2002026935A2 TGF-β INHIBITORS AND METHODS |
| 04/04/2002 | WO2002026929A2 Kini-3 motor protein and methods for its use |
| 04/04/2002 | WO2002026833A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026782A2 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |